AJP - GI Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol (January 19, 2006). doi:10.1152/ajpgi.00562.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/6/G1131    most recent
00562.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (16)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anthoni, C.
Right arrow Articles by Krieglstein, C. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anthoni, C.
Right arrow Articles by Krieglstein, C. F.
Submitted on December 13, 2005
Accepted on January 15, 2006

Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitis

Christoph Anthoni1, Mike G. Laukoetter2, Emile Rijcken2, Thorsten Vowinkel2, Rudolf Mennigen2, Sarah Muller2, Norbert Senninger2, Janice Russell3, Johann Jauch4, Jochen Bergmann4, D. Neil Granger3*, and Christian F. Krieglstein2

1 Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center, Shreveport, LA, USA; Department of General Surgery, Westfalian Wilhelm's University, Muenster, Germany
2 Department of General Surgery, Westfalian Wilhelm's University, Muenster, Germany
3 Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center, Shreveport, LA, USA
4 Institute of Organic Chemistry II, Saarland University, Saarbruecken, Germany

* To whom correspondence should be addressed. E-mail: dgrang{at}lsuhsc.edu.

Recent clinical trials of the gum resin of Boswellia serrata have shown promising results in patients with ulcerative colitis. The objective of this study was to determine whether a semi-synthetic form of acetyl-11-keto-{beta}-boswellic acid (sAKBA), the most potent anti-inflammatory component of the resin, also confers protection in experimental murine colitis induced by dextran sodium sulphate (DSS), to compare its effects to standard medications of ulcerative colitis like steroids and to examine whether leukocyte-endothelial cell adhesion is a major target of action of sAKBA. Clinical measurements of disease activity and histology were used to assess disease progression while intravital microscopy was employed to monitor the adhesion of leukocytes and platelets in postcapillary venules of the inflamed colon. SAKBA treatment significantly blunted disease activity as assessed both grossly and by histology. Similarly, the recruitment of adherent leukocytes and platelets into inflamed colonic venules was profoundly reduced in mice treated with sAKBA. Since previous studies in the DSS model have shown that P-selectin mediates these blood cell-endothelial cell interactions, the expression of P-selectin in the colonic microcirculation was monitored using the dual radiolabelled antibody technique. The treatment of established colitis with sAKBA largely prevented the P-selectin upregulation normally associated with DSS colitis. All of the protective responses observed with sAKBA were comparable to that realized in mice treated with a corticosteroid. Our findings demonstrate an anti-inflammatory effect of semi-synthetic AKBA and indicate that P-selectin mediated recruitment of inflammatory cells is a major site of action of this novel anti-inflammatory agent.




This article has been cited by other articles:


Home page
Anticancer ResHome page
J.-J. LIU and R.-D. DUAN
LY294002 Enhances Boswellic Acid-induced Apoptosis in Colon Cancer Cells
Anticancer Res, August 1, 2009; 29(8): 2987 - 2991.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
O. Schreiber, J. Petersson, M. Phillipson, M. Perry, S. Roos, and L. Holm
Lactobacillus reuteri prevents colitis by reducing P-selectin-associated leukocyte- and platelet-endothelial cell interactions
Am J Physiol Gastrointest Liver Physiol, March 1, 2009; 296(3): G534 - G542.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
A. B. Kunnumakkara, A. S. Nair, B. Sung, M. K. Pandey, and B. B. Aggarwal
Boswellic Acid Blocks Signal Transducers and Activators of Transcription 3 Signaling, Proliferation, and Survival of Multiple Myeloma via the Protein Tyrosine Phosphatase SHP-1
Mol. Cancer Res., January 1, 2009; 7(1): 118 - 128.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. R. Bhonde, R. D. Gupte, S. D. Dadarkar, M. G. Jadhav, A. A. Tannu, P. Bhatt, D. R. Bhatia, N. K. Desai, V. Deore, N. Yewalkar, et al.
A novel mTOR inhibitor is efficacious in a murine model of colitis
Am J Physiol Gastrointest Liver Physiol, December 1, 2008; 295(6): G1237 - G1245.
[Abstract] [Full Text] [PDF]


Home page
Nutr Clin PractHome page
J. O. Clarke and G. E. Mullin
A Review of Complementary and Alternative Approaches to Immunomodulation
Nutr Clin Pract, February 1, 2008; 23(1): 49 - 62.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
E. Rijcken, R. B. Mennigen, S. D. Schaefer, M. G. Laukoetter, C. Anthoni, H.-U. Spiegel, M. Bruewer, N. Senninger, and C. F. Krieglstein
PECAM-1 (CD 31) mediates transendothelial leukocyte migration in experimental colitis
Am J Physiol Gastrointest Liver Physiol, August 1, 2007; 293(2): G446 - G452.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.